Fe/Cu Bimetallic Nanozyme Co‐Assembled with 177Lu and Tanshinone for Quadruple‐Synergistic Tumor‐Specific Therapy (Adv. Healthcare Mater. 9/2025)
Advanced Healthcare Materials, Volume 14, Issue 9, April 4, 2025.
Synergistic Therapy
Nanozyme carriers co-deliver natural products and radionuclides for quadruple-synergistic tumor-specific therapy. More details can be found in article 2402696 by Xianyu Zhu, Han Lv, Jianhua Gong, Ji gang Yang, and co-workers.
